Could Individuals From Countries Using BCG Vaccination Be Resistant to SARS-COV-2 Induced Infections?

Date

2020-01-01

Author

Ayanoğlu, İhsan Cihan
İpekoğlu, Emre Mert
Yazar, Volkan
Yilmaz, Ismail Cem
Gürsel, Mayda

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

20
views

0
downloads

Cite This

The lower than expected number of SARS-CoV-2 cases in countries with fragile health systems is puzzling. Herein, we hypothesize that BCG vaccination policies and vaccine strain preferences adopted by different countries might influence the SARS-CoV-2 transmission patterns and/or COVID-19 associated morbidity and mortality. We also postulate that until a specific vaccine is developed, SARS-CoV-2 vulnerable populations could be immunized with BCG vaccines to attain heterologous nonspecific protection from the new coronavirus. In the lights of our investigations the most resistant countries appear to be the ones using Group I BCG strain. Within these countries, however, those who employs Russian strain is even more protected against COVID-19 infection.

Subject Keywords

BCG, COVID-19, SARS-CoV-2 infections, Protection

URI

https://hdl.handle.net/11511/47379

Collections

Department of Biology, Article